for intermediate-risk PCa, aiming to selectively target localized cancerous lesions while preserving healthy tissue

of various cancers, notably HCC. A major focus in recent studies has been on the epigenetic regulation of mi

and genomics have enabled the identification of specific molecular pathways and targets, paving the way

within the cardiovascular landscape. This review focuses on “immuno-miRs,” a class of mi

Показатели «целевого» уровня внутриглазного давления у пациентов с разными стадиями глаукомы низкого давленияTarget intraocular pressure level in patients with different stages of low tension glaucoma

of global death. The purpose of our bioinformatics analysis was to detect viable pathophysiological targets

Комбинированная таргетная терапия ингибиторами BRAF и MEK в сочетании с иммунотерапией (атезолизумаб + вемурафениб + кобиметиниб) при метастатической меланоме кожи (клинический случай)Combination BRAF/MEK Inhibitor Targeted Therapy and Immunotherapy (atezolizumab + vemurafenib

focusing on immunotherapy in OC; nevertheless, there are still no FDA-approved indications. Personalized

-3p), and their target protein-coding genes (PTEN, TGFB2, FOXO3, KEAP1) in the TGF-β/SMAD3, Wnt